Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole

• Status: Completed
• Trial end date: 2009-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine if the concomitant administration of either ketoconazole or fluconazole with BMS-708163 will affect the PK of BMS-708163 and to assess safety and tolerability of BMS-708163

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: Fluconazole; Ketoconazole

Criteria

Inclusion Criteria:

• Healthy male and postmenopausal female subjects 18-55 yrs old inclusive

Exclusion:

• Premenopausal women